Industry Research Reports
Home > Reports > Chemical & Material > Global Sophorolipid Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Sophorolipid Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-26
Pages: 133 Pages
Report ld: 5277962
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Sophorolipid market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Oil & Gas accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Sophorolipid leading manufacturers including Evonik, Saraya Co., Ltd., Ecover, Allied Carbon Solutions, MG Intobio, SyntheZyme LLC, Shandong Mei Chen Technology, Henkel, Groupe Soliance, Envgreen Biotechnology, etc., dominate supply; the top five capture approximately % of global revenue, with Evonik leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Sophorolipid market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Evonik
- Saraya Co., Ltd.
- Ecover
- Allied Carbon Solutions
- MG Intobio
- SyntheZyme LLC
- Shandong Mei Chen Technology
- Henkel
- Groupe Soliance
- Envgreen Biotechnology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Lactonic Sophorolipid
- Acidic Sophorolipid
Segment by Application
- Oil & Gas
- Bioremediation
- Medicine & Pharmaceuticals
- Cosmetics & Detergents
- Agriculture
- Food Industry
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Sophorolipid study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Sophorolipid: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Sophorolipid Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Lactonic Sophorolipid
1.2.3 Acidic Sophorolipid
1.3 Market Segmentation by Application
1.3.1 Global Sophorolipid Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Oil & Gas
1.3.3 Bioremediation
1.3.4 Medicine & Pharmaceuticals
1.3.5 Cosmetics & Detergents
1.3.6 Agriculture
1.3.7 Food Industry
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sophorolipid Revenue Estimates and Forecasts 2020-2031
2.2 Global Sophorolipid Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Sophorolipid Sales Estimates and Forecasts 2020-2031
2.4 Global Sophorolipid Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Sophorolipid Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Sophorolipid Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Sophorolipid Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Lactonic Sophorolipid Market Size by Manufacturers
4.5.2 Acidic Sophorolipid Market Size by Manufacturers
4.6 Global Sophorolipid Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Sophorolipid Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Sophorolipid Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Sophorolipid Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Sophorolipid Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Sophorolipid Sales and Revenue by Type (2020-2031)
7.4 North America Sophorolipid Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Sophorolipid Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Sophorolipid Sales and Revenue by Type (2020-2031)
8.4 Europe Sophorolipid Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Sophorolipid Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Sophorolipid Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Sophorolipid Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Sophorolipid Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Sophorolipid Sales and Revenue by Type (2020-2031)
10.4 Central and South America Sophorolipid Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Sophorolipid Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Sophorolipid Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Sophorolipid Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Sophorolipid Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Evonik
12.1.1 Evonik Corporation Information
12.1.2 Evonik Business Overview
12.1.3 Evonik Sophorolipid Product Models, Descriptions and Specifications
12.1.4 Evonik Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Evonik Sophorolipid Sales by Product in 2024
12.1.6 Evonik Sophorolipid Sales by Application in 2024
12.1.7 Evonik Sophorolipid Sales by Geographic Area in 2024
12.1.8 Evonik Sophorolipid SWOT Analysis
12.1.9 Evonik Recent Developments
12.2 Saraya Co., Ltd.
12.2.1 Saraya Co., Ltd. Corporation Information
12.2.2 Saraya Co., Ltd. Business Overview
12.2.3 Saraya Co., Ltd. Sophorolipid Product Models, Descriptions and Specifications
12.2.4 Saraya Co., Ltd. Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Saraya Co., Ltd. Sophorolipid Sales by Product in 2024
12.2.6 Saraya Co., Ltd. Sophorolipid Sales by Application in 2024
12.2.7 Saraya Co., Ltd. Sophorolipid Sales by Geographic Area in 2024
12.2.8 Saraya Co., Ltd. Sophorolipid SWOT Analysis
12.2.9 Saraya Co., Ltd. Recent Developments
12.3 Ecover
12.3.1 Ecover Corporation Information
12.3.2 Ecover Business Overview
12.3.3 Ecover Sophorolipid Product Models, Descriptions and Specifications
12.3.4 Ecover Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Ecover Sophorolipid Sales by Product in 2024
12.3.6 Ecover Sophorolipid Sales by Application in 2024
12.3.7 Ecover Sophorolipid Sales by Geographic Area in 2024
12.3.8 Ecover Sophorolipid SWOT Analysis
12.3.9 Ecover Recent Developments
12.4 Allied Carbon Solutions
12.4.1 Allied Carbon Solutions Corporation Information
12.4.2 Allied Carbon Solutions Business Overview
12.4.3 Allied Carbon Solutions Sophorolipid Product Models, Descriptions and Specifications
12.4.4 Allied Carbon Solutions Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Allied Carbon Solutions Sophorolipid Sales by Product in 2024
12.4.6 Allied Carbon Solutions Sophorolipid Sales by Application in 2024
12.4.7 Allied Carbon Solutions Sophorolipid Sales by Geographic Area in 2024
12.4.8 Allied Carbon Solutions Sophorolipid SWOT Analysis
12.4.9 Allied Carbon Solutions Recent Developments
12.5 MG Intobio
12.5.1 MG Intobio Corporation Information
12.5.2 MG Intobio Business Overview
12.5.3 MG Intobio Sophorolipid Product Models, Descriptions and Specifications
12.5.4 MG Intobio Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 MG Intobio Sophorolipid Sales by Product in 2024
12.5.6 MG Intobio Sophorolipid Sales by Application in 2024
12.5.7 MG Intobio Sophorolipid Sales by Geographic Area in 2024
12.5.8 MG Intobio Sophorolipid SWOT Analysis
12.5.9 MG Intobio Recent Developments
12.6 SyntheZyme LLC
12.6.1 SyntheZyme LLC Corporation Information
12.6.2 SyntheZyme LLC Business Overview
12.6.3 SyntheZyme LLC Sophorolipid Product Models, Descriptions and Specifications
12.6.4 SyntheZyme LLC Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 SyntheZyme LLC Recent Developments
12.7 Shandong Mei Chen Technology
12.7.1 Shandong Mei Chen Technology Corporation Information
12.7.2 Shandong Mei Chen Technology Business Overview
12.7.3 Shandong Mei Chen Technology Sophorolipid Product Models, Descriptions and Specifications
12.7.4 Shandong Mei Chen Technology Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Shandong Mei Chen Technology Recent Developments
12.8 Henkel
12.8.1 Henkel Corporation Information
12.8.2 Henkel Business Overview
12.8.3 Henkel Sophorolipid Product Models, Descriptions and Specifications
12.8.4 Henkel Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Henkel Recent Developments
12.9 Groupe Soliance
12.9.1 Groupe Soliance Corporation Information
12.9.2 Groupe Soliance Business Overview
12.9.3 Groupe Soliance Sophorolipid Product Models, Descriptions and Specifications
12.9.4 Groupe Soliance Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Groupe Soliance Recent Developments
12.10 Envgreen Biotechnology
12.10.1 Envgreen Biotechnology Corporation Information
12.10.2 Envgreen Biotechnology Business Overview
12.10.3 Envgreen Biotechnology Sophorolipid Product Models, Descriptions and Specifications
12.10.4 Envgreen Biotechnology Sophorolipid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Envgreen Biotechnology Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Sophorolipid Industry Chain
13.2 Sophorolipid Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Sophorolipid Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Sophorolipid Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Sophorolipid Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Sophorolipid Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Sophorolipid Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Sophorolipid Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Sophorolipid Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Sophorolipid Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Sophorolipid Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Sophorolipid Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 7. Global Sophorolipid Sales by Region (2020-2025) & (MT)
Table 8. Global Sophorolipid Sales by Region (2026-2031) & (MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Sophorolipid Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 11. Global Sophorolipid Production by Region (2020-2025) & (MT)
Table 12. Global Sophorolipid Production by Region (2026-2031) & (MT)
Table 13. Global Sophorolipid Sales by Manufacturers (2020-2025) & (MT)
Table 14. Global Sophorolipid Sales Share by Manufacturers (2020-2025)
Table 15. Global Sophorolipid Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Sophorolipid Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Sophorolipid by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sophorolipid as of 2024)
Table 19. Global Sophorolipid Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Sophorolipid Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Sophorolipid Manufacturing Base and Headquarters
Table 22. Global Sophorolipid Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Sophorolipid Sales by Type (2020-2025) & (MT)
Table 26. Global Sophorolipid Sales by Type (2026-2031) & (MT)
Table 27. Global Sophorolipid Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Sophorolipid Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Sophorolipid ASP by Type (2020-2031) & (USD/MT)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Sophorolipid Sales by Application (2020-2025) & (MT)
Table 32. Global Sophorolipid Sales by Application (2026-2031) & (MT)
Table 33. Sophorolipid High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Sophorolipid Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Sophorolipid Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Sophorolipid ASP by Application (2020-2031) & (USD/MT)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Sophorolipid Growth Accelerators and Market Barriers
Table 40. North America Sophorolipid Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Sophorolipid Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Sophorolipid Growth Accelerators and Market Barriers
Table 43. Europe Sophorolipid Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Sophorolipid Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Sophorolipid Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Sophorolipid Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Sophorolipid Growth Accelerators and Market Barriers
Table 48. Southeast Asia Sophorolipid Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Sophorolipid Investment Opportunities and Key Challenges
Table 50. Central and South America Sophorolipid Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Sophorolipid Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Sophorolipid Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Evonik Corporation Information
Table 54. Evonik Description and Major Businesses
Table 55. Evonik Product Models, Descriptions and Specifications
Table 56. Evonik Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Evonik Sales Value Proportion by Product in 2024
Table 58. Evonik Sales Value Proportion by Application in 2024
Table 59. Evonik Sales Value Proportion by Geographic Area in 2024
Table 60. Evonik Sophorolipid SWOT Analysis
Table 61. Evonik Recent Developments
Table 62. Saraya Co., Ltd. Corporation Information
Table 63. Saraya Co., Ltd. Description and Major Businesses
Table 64. Saraya Co., Ltd. Product Models, Descriptions and Specifications
Table 65. Saraya Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 66. Saraya Co., Ltd. Sales Value Proportion by Product in 2024
Table 67. Saraya Co., Ltd. Sales Value Proportion by Application in 2024
Table 68. Saraya Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 69. Saraya Co., Ltd. Sophorolipid SWOT Analysis
Table 70. Saraya Co., Ltd. Recent Developments
Table 71. Ecover Corporation Information
Table 72. Ecover Description and Major Businesses
Table 73. Ecover Product Models, Descriptions and Specifications
Table 74. Ecover Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Ecover Sales Value Proportion by Product in 2024
Table 76. Ecover Sales Value Proportion by Application in 2024
Table 77. Ecover Sales Value Proportion by Geographic Area in 2024
Table 78. Ecover Sophorolipid SWOT Analysis
Table 79. Ecover Recent Developments
Table 80. Allied Carbon Solutions Corporation Information
Table 81. Allied Carbon Solutions Description and Major Businesses
Table 82. Allied Carbon Solutions Product Models, Descriptions and Specifications
Table 83. Allied Carbon Solutions Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. Allied Carbon Solutions Sales Value Proportion by Product in 2024
Table 85. Allied Carbon Solutions Sales Value Proportion by Application in 2024
Table 86. Allied Carbon Solutions Sales Value Proportion by Geographic Area in 2024
Table 87. Allied Carbon Solutions Sophorolipid SWOT Analysis
Table 88. Allied Carbon Solutions Recent Developments
Table 89. MG Intobio Corporation Information
Table 90. MG Intobio Description and Major Businesses
Table 91. MG Intobio Product Models, Descriptions and Specifications
Table 92. MG Intobio Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. MG Intobio Sales Value Proportion by Product in 2024
Table 94. MG Intobio Sales Value Proportion by Application in 2024
Table 95. MG Intobio Sales Value Proportion by Geographic Area in 2024
Table 96. MG Intobio Sophorolipid SWOT Analysis
Table 97. MG Intobio Recent Developments
Table 98. SyntheZyme LLC Corporation Information
Table 99. SyntheZyme LLC Description and Major Businesses
Table 100. SyntheZyme LLC Product Models, Descriptions and Specifications
Table 101. SyntheZyme LLC Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. SyntheZyme LLC Recent Developments
Table 103. Shandong Mei Chen Technology Corporation Information
Table 104. Shandong Mei Chen Technology Description and Major Businesses
Table 105. Shandong Mei Chen Technology Product Models, Descriptions and Specifications
Table 106. Shandong Mei Chen Technology Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Shandong Mei Chen Technology Recent Developments
Table 108. Henkel Corporation Information
Table 109. Henkel Description and Major Businesses
Table 110. Henkel Product Models, Descriptions and Specifications
Table 111. Henkel Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Henkel Recent Developments
Table 113. Groupe Soliance Corporation Information
Table 114. Groupe Soliance Description and Major Businesses
Table 115. Groupe Soliance Product Models, Descriptions and Specifications
Table 116. Groupe Soliance Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Groupe Soliance Recent Developments
Table 118. Envgreen Biotechnology Corporation Information
Table 119. Envgreen Biotechnology Description and Major Businesses
Table 120. Envgreen Biotechnology Product Models, Descriptions and Specifications
Table 121. Envgreen Biotechnology Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Envgreen Biotechnology Recent Developments
Table 123. Key Raw Materials Distribution
Table 124. Raw Materials Key Suppliers
Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 126. Milestones in Production Technology Evolution
Table 127. Distributors List
Table 128. Market Trends and Market Evolution
Table 129. Market Drivers and Opportunities
Table 130. Market Challenges, Risks, and Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Sophorolipid Product Picture
Figure 2. Global Sophorolipid Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Lactonic Sophorolipid Product Picture
Figure 4. Acidic Sophorolipid Product Picture
Figure 5. Global Sophorolipid Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Oil & Gas
Figure 7. Bioremediation
Figure 8. Medicine & Pharmaceuticals
Figure 9. Cosmetics & Detergents
Figure 10. Agriculture
Figure 11. Food Industry
Figure 12. Others
Figure 13. Sophorolipid Report Years Considered
Figure 14. Global Sophorolipid Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 16. Global Sophorolipid Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Sophorolipid Revenue Market Share by Region (2020-2031)
Figure 18. Global Sophorolipid Sales (2020-2031) & (MT)
Figure 19. Global Sophorolipid Sales (CAGR) by Region (2020-2031) (MT)
Figure 20. Global Sophorolipid Sales Market Share by Region (2020-2031)
Figure 21. Global Sophorolipid Capacity, Production and Utilization (2020-2031) & (MT)
Figure 22. Global Sophorolipid Production Trend by Region (2020-2031) (MT)
Figure 23. Global Sophorolipid Production Market Share by Region (2020-2031)
Figure 24. Production Capacity Enablers & Constraints
Figure 25. Sophorolipid Production Growth Rate in North America (2020-2031) & (MT)
Figure 26. Sophorolipid Production Growth Rate in Europe (2020-2031) & (MT)
Figure 27. Sophorolipid Production Growth Rate in China (2020-2031) & (MT)
Figure 28. Sophorolipid Production Growth Rate in Japan (2020-2031) & (MT)
Figure 29. Top 5 and Top 10 Manufacturers Sophorolipid Sales Volume Market Share in 2024
Figure 30. Global Sophorolipid Revenue Market Share Ranking (2024)
Figure 31. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 32. Lactonic Sophorolipid Revenue Market Share by Manufacturer in 2024
Figure 33. Acidic Sophorolipid Revenue Market Share by Manufacturer in 2024
Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 36. Global Sophorolipid Sales Market Share by Type (2020-2031)
Figure 37. Global Sophorolipid Revenue Market Share by Type (2020-2031)
Figure 38. Global Sophorolipid Sales Market Share by Application (2020-2031)
Figure 39. Global Sophorolipid Revenue Market Share by Application (2020-2031)
Figure 40. North America Sophorolipid Sales YoY (2020-2031) & (MT)
Figure 41. North America Sophorolipid Revenue YoY (2020-2031) & (US$ Million)
Figure 42. North America Top 5 Manufacturers Sophorolipid Sales Revenue (US$ Million) in 2024
Figure 43. North America Sophorolipid Sales Volume (MT) by Type (2020- 2031)
Figure 44. North America Sophorolipid Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 45. North America Sophorolipid Sales Volume (MT) by Application (2020-2031)
Figure 46. North America Sophorolipid Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. US Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 48. Canada Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 49. Mexico Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 50. Europe Sophorolipid Sales YoY (2020-2031) & (MT)
Figure 51. Europe Sophorolipid Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Europe Top 5 Manufacturers Sophorolipid Sales Revenue (US$ Million) in 2024
Figure 53. Europe Sophorolipid Sales Volume (MT) by Type (2020-2031)
Figure 54. Europe Sophorolipid Sales Revenue (US$ Million) by Type (2020-2031)
Figure 55. Europe Sophorolipid Sales Volume (MT) by Application (2020-2031)
Figure 56. Europe Sophorolipid Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Germany Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 58. France Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 59. U.K. Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 60. Italy Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 61. Russia Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Sophorolipid Sales YoY (2020-2031) & (MT)
Figure 63. Asia-Pacific Sophorolipid Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Top 8 Manufacturers Sophorolipid Sales Revenue (US$ Million) in 2024
Figure 65. Asia-Pacific Sophorolipid Sales Volume (MT) by Type (2020- 2031)
Figure 66. Asia-Pacific Sophorolipid Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 67. Asia-Pacific Sophorolipid Sales Volume (MT) by Application (2020-2031)
Figure 68. Asia-Pacific Sophorolipid Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Indonesia Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 70. Japan Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 71. South Korea Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 72. China Taiwan Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 73. India Sophorolipid Revenue (2020-2031) & (US$ Million)
Figure 74. Central and South America Sophorolipid Sales YoY (2020-2031) & (MT)
Figure 75. Central and South America Sophorolipid Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Central and South America Top 5 Manufacturers Sophorolipid Sales Revenue (US$ Million) in 2024
Figure 77. Central and South America Sophorolipid Sales Volume (MT) by Type (2021-2031)
Figure 78. Central and South America Sophorolipid Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Central and South America Sophorolipid Sales Volume (MT) by Application (2020-2031)
Figure 80. Central and South America Sophorolipid Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. Brazil Sophorolipid Revenue (2020-2025) & (US$ Million)
Figure 82. Argentina Sophorolipid Revenue (2020-2025) & (US$ Million)
Figure 83. Middle East, and Africa Sophorolipid Sales YoY (2020-2031) & (MT)
Figure 84. Middle East and Africa Sophorolipid Revenue YoY (2020-2031) & (US$ Million)
Figure 85. Middle East and Africa Top 5 Manufacturers Sophorolipid Sales Revenue (US$ Million) in 2024
Figure 86. Middle East and Africa Sophorolipid Sales Volume (MT) by Type (2021-2031)
Figure 87. South America Sophorolipid Sales Revenue (US$ Million) by Type (2020-2031)
Figure 88. Middle East and Africa Sophorolipid Sales Volume (MT) by Application (2020-2031)
Figure 89. Middle East and Africa Sophorolipid Sales Revenue (US$ Million) by Application (2020-2031)
Figure 90. GCC Countries Sophorolipid Revenue (2020-2025) & (US$ Million)
Figure 91. Turkey Sophorolipid Revenue (2020-2025) & (US$ Million)
Figure 92. Egypt Sophorolipid Revenue (2020-2025) & (US$ Million)
Figure 93. South Africa Sophorolipid Revenue (2020-2025) & (US$ Million)
Figure 94. Sophorolipid Industry Chain Mapping
Figure 95. Regional Sophorolipid Manufacturing Base Distribution (%)
Figure 96. Sophorolipid Production Process
Figure 97. Regional Sophorolipid Production Cost Structure
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Sophorolipid market?
The top companies in the global Sophorolipid market are Evonik、Saraya Co., Ltd.、Ecover.
Related Reports
Sophorolipid- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sophorolipid was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 129
USD 3950.00
(Single User License)
Global Sophorolipid Market Research Report 2026
The global Sophorolipid market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 134
USD 2900.00
(Single User License)
Global Sophorolipid Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sophorolipid market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 79
USD 4250.00
(Single User License)
Sophorolipid- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sophorolipid was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 96
USD 3950.00
(Single User License)
Global Sophorolipid Market Research Report 2025
The global market for Sophorolipid was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 93
USD 2900.00
(Single User License)
Global Sophorolipid Market Insights, Forecast to 2030
The global Sophorolipid market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-15
Pages: 108
USD 4900.00
(Single User License)
Sophorolipid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Sophorolipid was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 117
USD 3950.00
(Single User License)
Global Sophorolipid Market Research Report 2024
The global Sophorolipid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 96
USD 2900.00
(Single User License)
Sophorolipid- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sophorolipid was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 129
USD 3950.00 (Single User License)Global Sophorolipid Market Research Report 2026
The global Sophorolipid market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 134
USD 2900.00 (Single User License)Global Sophorolipid Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sophorolipid market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 79
USD 4250.00 (Single User License)Sophorolipid- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sophorolipid was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 96
USD 3950.00 (Single User License)Global Sophorolipid Market Research Report 2025
The global market for Sophorolipid was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 93
USD 2900.00 (Single User License)Global Sophorolipid Market Insights, Forecast to 2030
The global Sophorolipid market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-15
Pages: 108
USD 4900.00 (Single User License)Sophorolipid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Sophorolipid was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 117
USD 3950.00 (Single User License)Global Sophorolipid Market Research Report 2024
The global Sophorolipid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 96
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now